SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001358403-19-000058
Filing Date
2019-05-07
Accepted
2019-05-07 16:32:00
Documents
69
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a2019q110q.htm 10-Q 1042616
2 EXHIBIT 10.1 exhibit101-supplyagreement.htm EX-10.1 380615
3 EXHIBIT 10.2 exhibit102-2014equityincen.htm EX-10.2 195893
4 EXHIBIT 31.1 exh3112019q1.htm EX-31.1 13611
5 EXHIBIT 31.2 exh3122019q1.htm EX-31.2 14273
6 EXHIBIT 32.1 exh3212019q1.htm EX-32.1 12614
  Complete submission text file 0001358403-19-000058.txt   5560572

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT blcm-20190331.xml EX-101.INS 942966
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blcm-20190331.xsd EX-101.SCH 34059
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT blcm-20190331_cal.xml EX-101.CAL 82640
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT blcm-20190331_def.xml EX-101.DEF 155839
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blcm-20190331_lab.xml EX-101.LAB 524328
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blcm-20190331_pre.xml EX-101.PRE 304829
Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030
Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36783 | Film No.: 19803587
SIC: 2834 Pharmaceutical Preparations